Mexico: Price fixing confirmed in National health service

Mexico’s Supreme Court has upheld a 2010 resolution by the Federal Competition Commission (Now COFECE), which imposed sanctions for up to 21 million pesos on several pharmaceutical companies accused of price fixing.

The companies have been accused of coordinating to manipulate the prices in contests for the provision of insulin, electrolyte and saline solution to Mexico’s national health service. The decision marks the first time the court has confirmed the existence of absolute monopolistic behavior.

The court upheld the validity of the economic analysis used to determine the existence price-fixing agreements between the companies, and whether these agreements had negatively affected the market dynamics, equilibrium, or otherwise been detrimental to competition.

Full content: El Diario

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.